Global Solid Tumors Drugs Sales Market Report Forecast 2017 to 2022

April 2017 | 114 pages | ID: G09C86AAD9FEN
S&P Consulting

Abstracts

Delivery of the Report will take 2-3 working days once order is placed.

The report offers a comprehensive evaluation of the market. It does so via in-depth insights, understanding market evolution by tracking historical developments, and analyzing the present scenario and future projections based on optimistic and likely scenarios. Each research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology developments, types, applications, and the competitive landscape.

The study is a source of reliable data on:

• Key market segments and sub-segments
• Evolving market trends and dynamics
• Changing supply and demand scenarios
• Quantifying market opportunities through market sizing and market forecasting
• Tracking current trends/opportunities/challenges
• Competitive insights
• Opportunity mapping in terms of technological breakthroughs

This research report analyzes this market on the basis of its market segments, major geographies, and current market trends. Geographies analyzed under this research report include:
United States
China
Europe
Japan

The Major players reported in the market include:
Hoffmann-La Roche
Novartis
Celgene
Johnson & Johnson
Pfizer
BMS
AbbVie
AbGenomics
ADC Therapeutics

Product Segment Analysis:
Type 1
Type 2
Type 3

Application Segment Analysis:
Application 1
Application 2
Application 3

Reasons for Buying this Report

• This report provides pin-point analysis for changing competitive dynamics
• It provides a forward looking perspective on different factors driving or restraining market growth
• It provides a six-year forecast assessed on the basis of how the market is predicted to grow
• It helps in understanding the key product segments and their future
• It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
• It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments

It provides distinctive graphics and exemplified analysis of major market segments

Contents

1 SOLID TUMORS DRUGS MARKET OVERVIEW

1.1 Product Overview and Scope of Solid Tumors Drugs
1.2 Classification of Solid Tumors Drugs
  1.2.1 Type
  1.2.2 Type
  1.2.3 Type
1.3 Application of Solid Tumors Drugs
  1.3.2 Application
  1.3.3 Application
  1.3.4 Application
1.4 Solid Tumors Drugs Market States Status and Prospect (2012-2022) by Regions
  1.4.1 United States
  1.4.2 China
  1.4.3 Europe
  1.4.4 Japan
1.5 Global Market Size of Solid Tumors Drugs (2012-2022)
  1.5.1 Global Solid Tumors Drugs Sales and Growth Rate (2012-2022)
  1.5.2 Global Solid Tumors Drugs Revenue and Growth Rate (2012-2022)

2 GLOBAL ECONOMIC IMPACT ON SOLID TUMORS DRUGS INDUSTRY

2.1 Global Macroeconomic Environment Analysis
  2.1.1 Global Macroeconomic Analysis
  2.1.2 Global Macroeconomic Environment Development Trend
2.2 Global Macroeconomic Environment Analysis by Regions

3 SOLID TUMORS DRUGS MANUFACTURING COST ANALYSIS

3.1 Solid Tumors Drugs Key Raw Materials Analysis
  3.1.1 Key Raw Materials
  3.1.2 Price Trend of Key Raw Materials
  3.1.3 Key Suppliers of Raw Materials
  3.1.4 Market Concentration Rate of Raw Materials
3.2 Proportion of Manufacturing Cost Structure
  3.2.1 Raw Materials
  3.2.2 Labor Cost
  3.2.3 Manufacturing Process Analysis of Solid Tumors Drugs

4 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

4.1 Solid Tumors Drugs Industrial Chain Analysis
4.2 Upstream Raw Materials Sourcing
4.3 Raw Materials Sources of Solid Tumors Drugs Major Manufacturers in 2016
4.4 Downstream Buyers

5 GLOBAL SOLID TUMORS DRUGS COMPETITION BY MANUFACTURERS, TYPE AND APPLICATION

5.1 Global Solid Tumors Drugs Market Competition by Manufacturers
  5.1.1 Global Solid Tumors Drugs Sales and Market Share of Key Manufacturers (2012-2017)
  5.1.2 Global Solid Tumors Drugs Revenue and Share by Manufacturers (2012-2017)
5.2 Global Solid Tumors Drugs (Volume and Value) by Type
  5.5.1 Global Solid Tumors Drugs Sales and Market Share by Type (2012-2017)
  5.5.2 Global Solid Tumors Drugs Revenue and Market Share by Type (2012-2017)
5.3 Global Solid Tumors Drugs (Volume and Value) by Regions
  5.3.1 Global Solid Tumors Drugs Sales and Market Share by Regions (2012-2017)
  5.3.2 Global Solid Tumors Drugs Revenue and Market Share by Regions (2012-2017)
5.4 Global Solid Tumors Drugs (Volume) by Application

6 UNITED STATES SOLID TUMORS DRUGS (VOLUME, VALUE AND SALES PRICE)

6.1 United States Solid Tumors Drugs Sales and Value (2012-2017)
  6.1.1 United States Solid Tumors Drugs Sales and Growth Rate (2012-2017)
  6.1.2 United States Solid Tumors Drugs Revenue and Growth Rate (2012-2017)
  6.1.3 United States Solid Tumors Drugs Sales Price Trend (2012-2017)
6.2 United States Solid Tumors Drugs Sales and Market Share by Manufacturers
6.3 United States Solid Tumors Drugs Sales and Market Share by Type
6.4 United States Solid Tumors Drugs Sales and Market Share by Application

7 CHINA SOLID TUMORS DRUGS (VOLUME, VALUE AND SALES PRICE)

7.1 China Solid Tumors Drugs Sales and Value (2012-2017)
  7.1.1 China Solid Tumors Drugs Sales and Growth Rate (2012-2017)
  7.1.2 China Solid Tumors Drugs Revenue and Growth Rate (2012-2017)
  7.1.3 China Solid Tumors Drugs Sales Price Trend (2012-2017)
7.2 China Solid Tumors Drugs Sales and Market Share by Manufacturers
7.3 China Solid Tumors Drugs Sales and Market Share by Type
7.4 China Solid Tumors Drugs Sales and Market Share by Application

8 EUROPE SOLID TUMORS DRUGS (VOLUME, VALUE AND SALES PRICE)

8.1 Europe Solid Tumors Drugs Sales and Value (2012-2017)
  8.1.1 Europe Solid Tumors Drugs Sales and Growth Rate (2012-2017)
  8.1.2 Europe Solid Tumors Drugs Revenue and Growth Rate (2012-2017)
  8.1.3 Europe Solid Tumors Drugs Sales Price Trend (2012-2017)
8.2 Europe Solid Tumors Drugs Sales and Market Share by Manufacturers
8.3 Europe Solid Tumors Drugs Sales and Market Share by Type
8.4 Europe Solid Tumors Drugs Sales and Market Share by Application

9 JAPAN SOLID TUMORS DRUGS (VOLUME, VALUE AND SALES PRICE)

9.1 Japan Solid Tumors Drugs Sales and Value (2012-2017)
  9.1.1 Japan Solid Tumors Drugs Sales and Growth Rate (2012-2017)
  9.1.2 Japan Solid Tumors Drugs Revenue and Growth Rate (2012-2017)
  9.1.3 Japan Solid Tumors Drugs Sales Price Trend (2012-2017)
9.2 Japan Solid Tumors Drugs Sales and Market Share by Manufacturers
9.3 Japan Solid Tumors Drugs Sales and Market Share by Type
9.4 Japan Solid Tumors Drugs Sales and Market Share by Application

10 GLOBAL SOLID TUMORS DRUGS MANUFACTURERS ANALYSIS

10.1 Hoffmann-La Roche
  10.1.1 Company Basic Information, Manufacturing Base and Competitors
  10.1.2 Product Type, Application and Specification
  10.1.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.1.4 Business Overview
10.2 Novartis
  10.2.1 Company Basic Information, Manufacturing Base and Competitors
  10.2.2 Product Type, Application and Specification
  10.2.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.2.4 Business Overview
10.3 Celgene
  10.3.1 Company Basic Information, Manufacturing Base and Competitors
  10.3.2 Product Type, Application and Specification
  10.3.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.3.4 Business Overview
10.4 Johnson & Johnson
  10.4.1 Company Basic Information, Manufacturing Base and Competitors
  10.4.2 Product Type, Application and Specification
  10.4.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.4.4 Business Overview
10.5 Pfizer
  10.5.1 Company Basic Information, Manufacturing Base and Competitors
  10.5.2 Product Type, Application and Specification
  10.5.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.5.4 Business Overview
10.6 BMS
  10.6.1 Company Basic Information, Manufacturing Base and Competitors
  10.6.2 Product Type, Application and Specification
  10.6.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.6.4 Business Overview
10.7 AbbVie
  10.7.1 Company Basic Information, Manufacturing Base and Competitors
  10.7.2 Product Type, Application and Specification
  10.7.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.7.4 Business Overview
10.8 AbGenomics
  10.8.1 Company Basic Information, Manufacturing Base and Competitors
  10.8.2 Product Type, Application and Specification
  10.8.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.8.4 Business Overview
10.9 ADC Therapeutics
  10.9.1 Company Basic Information, Manufacturing Base and Competitors
  10.9.2 Product Type, Application and Specification
  10.9.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.9.4 Business Overview

11 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

11.1 Marketing Channel
  11.1.1 Direct Marketing
  11.1.2 Indirect Marketing
  11.1.3 Marketing Channel Development Trend
11.2 Market Positioning
  11.2.1 Pricing Strategy
  11.2.2 Brand Strategy
  11.2.3 Target Client
11.3 Distributors/Traders List

12 MARKET EFFECT FACTORS ANALYSIS

12.1 Technology Progress/Risk
  12.1.1 Substitutes Threat
  12.1.2 Technology Progress in Related Industry
12.2 Consumer Needs/Customer Preference Change
12.3 Economic/Political Environmental Change

13 GLOBAL SOLID TUMORS DRUGS MARKET FORECAST (2017-2022)

13.1 Global Solid Tumors Drugs Sales, Revenue Forecast (2017-2022)
13.2 Global Solid Tumors Drugs Sales Forecast by Regions (2017-2022)
13.3 Global Solid Tumors Drugs Sales Forecast by Type (2017-2022)
13.4 Global Solid Tumors Drugs Sales Forecast by Application (2017-2022)

14 APPENDIX

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Solid Tumors Drugs
Table Classification of Solid Tumors Drugs
Figure Global Sales Market Share of Solid Tumors Drugs by Type in 2016
Table Applications of Solid Tumors Drugs
Figure Global Sales Market Share of Solid Tumors Drugs by Application in 2016
Figure United States Solid Tumors Drugs Revenue and Growth Rate (2012-2022)
Figure China Solid Tumors Drugs Revenue and Growth Rate (2012-2022)
Figure Europe Solid Tumors Drugs Revenue and Growth Rate (2012-2022)
Figure Japan Solid Tumors Drugs Revenue and Growth Rate (2012-2022)
Figure Global Solid Tumors Drugs Sales and Growth Rate (2012-2022)
Figure Global Solid Tumors Drugs Revenue and Growth Rate (2012-2022)
Table Global Solid Tumors Drugs Sales of Key Manufacturers (2012-2017)
Table Global Solid Tumors Drugs Sales Share by Manufacturers (2012-2017)
Figure 2015 Solid Tumors Drugs Sales Share by Manufacturers
Figure 2016 Solid Tumors Drugs Sales Share by Manufacturers
Table Global Solid Tumors Drugs Revenue by Manufacturers (2012-2017)
Table Global Solid Tumors Drugs Revenue Share by Manufacturers (2012-2017)
Table 2015 Global Solid Tumors Drugs Revenue Share by Manufacturers
Table 2016 Global Solid Tumors Drugs Revenue Share by Manufacturers
Table Global Solid Tumors Drugs Sales and Market Share by Type (2012-2017)
Table Global Solid Tumors Drugs Sales Share by Type (2012-2017)
Figure Sales Market Share of Solid Tumors Drugs by Type (2012-2017)
Figure Global Solid Tumors Drugs Sales Growth Rate by Type (2012-2017)
Table Global Solid Tumors Drugs Revenue and Market Share by Type (2012-2017)
Table Global Solid Tumors Drugs Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Solid Tumors Drugs by Type (2012-2017)
Figure Global Solid Tumors Drugs Revenue Growth Rate by Type (2012-2017)
Table Global Solid Tumors Drugs Sales and Market Share by Regions (2012-2017)
Table Global Solid Tumors Drugs Sales Share by Regions (2012-2017)
Figure Sales Market Share of Solid Tumors Drugs by Regions (2012-2017)
Figure Global Solid Tumors Drugs Sales Growth Rate by Regions (2012-2017)
Table Global Solid Tumors Drugs Revenue and Market Share by Regions (2012-2017)
Table Global Solid Tumors Drugs Revenue Share by Regions (2012-2017)
Figure Revenue Market Share of Solid Tumors Drugs by Regions (2012-2017)
Figure Global Solid Tumors Drugs Revenue Growth Rate by Regions (2012-2017)
Table Global Solid Tumors Drugs Sales and Market Share by Application (2012-2017)
Table Global Solid Tumors Drugs Sales Share by Application (2012-2017)
Figure Sales Market Share of Solid Tumors Drugs by Application (2012-2017)
Figure Global Solid Tumors Drugs Sales Growth Rate by Application (2012-2017)
Figure United States Solid Tumors Drugs Sales and Growth Rate (2012-2017)
Figure United States Solid Tumors Drugs Revenue and Growth Rate (2012-2017)
Figure United States Solid Tumors Drugs Sales Price Trend (2012-2017)
Table United States Solid Tumors Drugs Sales by Manufacturers (2012-2017)
Table United States Solid Tumors Drugs Market Share by Manufacturers (2012-2017)
Table United States Solid Tumors Drugs Sales by Type (2012-2017)
Table United States Solid Tumors Drugs Market Share by Type (2012-2017)
Table United States Solid Tumors Drugs Sales by Application (2012-2017)
Table United States Solid Tumors Drugs Market Share by Application (2012-2017)
Figure China Solid Tumors Drugs Sales and Growth Rate (2012-2017)
Figure China Solid Tumors Drugs Revenue and Growth Rate (2012-2017)
Figure China Solid Tumors Drugs Sales Price Trend (2012-2017)
Table China Solid Tumors Drugs Sales by Manufacturers (2012-2017)
Table China Solid Tumors Drugs Market Share by Manufacturers (2012-2017)
Table China Solid Tumors Drugs Sales by Type (2012-2017)
Table China Solid Tumors Drugs Market Share by Type (2012-2017)
Table China Solid Tumors Drugs Sales by Application (2012-2017)
Table China Solid Tumors Drugs Market Share by Application (2012-2017)
Figure Europe Solid Tumors Drugs Sales and Growth Rate (2012-2017)
Figure Europe Solid Tumors Drugs Revenue and Growth Rate (2012-2017)
Figure Europe Solid Tumors Drugs Sales Price Trend (2012-2017)
Table Europe Solid Tumors Drugs Sales by Manufacturers (2012-2017)
Table Europe Solid Tumors Drugs Market Share by Manufacturers (2012-2017)
Table Europe Solid Tumors Drugs Sales by Type (2012-2017)
Table Europe Solid Tumors Drugs Market Share by Type (2012-2017)
Table Europe Solid Tumors Drugs Sales by Application (2012-2017)
Table Europe Solid Tumors Drugs Market Share by Application (2012-2017)
Figure Japan Solid Tumors Drugs Sales and Growth Rate (2012-2017)
Figure Japan Solid Tumors Drugs Revenue and Growth Rate (2012-2017)
Figure Japan Solid Tumors Drugs Sales Price Trend (2012-2017)
Table Japan Solid Tumors Drugs Sales by Manufacturers (2012-2017)
Table Japan Solid Tumors Drugs Market Share by Manufacturers (2012-2017)
Table Japan Solid Tumors Drugs Sales by Type (2012-2017)
Table Japan Solid Tumors Drugs Market Share by Type (2012-2017)
Table Japan Solid Tumors Drugs Sales by Application (2012-2017)
Table Japan Solid Tumors Drugs Market Share by Application (2012-2017)
Table Hoffmann-La Roche Basic Information List
Table Hoffmann-La Roche Solid Tumors Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Hoffmann-La Roche Solid Tumors Drugs Global Market Share (2012-2017)
Table Novartis Basic Information List
Table Novartis Solid Tumors Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Novartis Solid Tumors Drugs Global Market Share (2012-2017)
Table Celgene Basic Information List
Table Celgene Solid Tumors Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Celgene Solid Tumors Drugs Global Market Share (2012-2017)
Table Johnson & Johnson Basic Information List
Table Johnson & Johnson Solid Tumors Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Johnson & Johnson Solid Tumors Drugs Global Market Share (2012-2017)
Table Pfizer Basic Information List
Table Pfizer Solid Tumors Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Pfizer Solid Tumors Drugs Global Market Share (2012-2017)
Table BMS Basic Information List
Table BMS Solid Tumors Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure BMS Solid Tumors Drugs Global Market Share (2012-2017)
Table AbbVie Basic Information List
Table AbbVie Solid Tumors Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure AbbVie Solid Tumors Drugs Global Market Share (2012-2017)
Table AbGenomics Basic Information List
Table AbGenomics Solid Tumors Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure AbGenomics Solid Tumors Drugs Global Market Share (2012-2017)
Table ADC Therapeutics Basic Information List
Table ADC Therapeutics Solid Tumors Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure ADC Therapeutics Solid Tumors Drugs Global Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Solid Tumors Drugs
Figure Manufacturing Process Analysis of Solid Tumors Drugs
Figure Solid Tumors Drugs Industrial Chain Analysis
Table Raw Materials Sources of Solid Tumors Drugs Major Manufacturers in 2016
Table Major Buyers of Solid Tumors Drugs
Table Distributors/Traders List
Figure Global Solid Tumors Drugs Sales and Growth Rate Forecast (2017-2022)
Figure Global Solid Tumors Drugs Revenue and Growth Rate Forecast (2017-2022)
Table Global Solid Tumors Drugs Sales Forecast by Regions (2017-2022)
Table Global Solid Tumors Drugs Sales Forecast by Type (2017-2022)
Table Global Solid Tumors Drugs Sales Forecast by Application (2017-2022)

COMPANIES MENTIONED

Hoffmann-La Roche
Novartis
Celgene
Johnson & Johnson
Pfizer
BMS
AbbVie
AbGenomics
ADC Therapeutics
TG Therapeutics
Polaris Pharmaceuticals
Immunogen
CTI BioPharma
Chugai Pharmaceutical
NewLink Genetics